A Randomized Fellow-Eye Clinical Trial to Evaluate Patient Preference for Dexamethasone Intracanalicular Insert or Topical Prednisolone Acetate for Control of Postoperative Symptoms Following Bilateral Femtosecond Laser in Site Keratomileusis (LASIK).
Michael D GreenwoodRichard A GorhamKeeley R BoeverPublished in: Clinical ophthalmology (Auckland, N.Z.) (2020)
Patients undergoing elective bilateral femtosecond LASIK surgery overwhelmingly (by an 8-to-1 margin) preferred the dexamethasone insert to topical prednisolone acetate for postoperative treatment. The insert produced comparable ocular comfort, corneal staining, and visual acuity outcomes to topical prednisolone. The insert is an appropriate means of postoperative symptom control in this quality of life-conscious population.
Keyphrases
- patients undergoing
- wound healing
- clinical trial
- case report
- low dose
- minimally invasive
- coronary artery bypass
- physical activity
- study protocol
- adipose tissue
- acute coronary syndrome
- metabolic syndrome
- open label
- combination therapy
- percutaneous coronary intervention
- sleep quality
- insulin resistance
- replacement therapy
- patient reported
- optic nerve
- flow cytometry